A passed PFAS test is a checkpoint. Keeping bulk production compliant requires control of materials, suppliers and changes.
For bags and luggage, the conversation often begins with a fabric supplier saying “PFAS-free.” The harder question is whether the brand can connect that statement to the actual material, finishing process and production order.
The short version
- Define the market and product requirement before ordering tests.
- Trace chemical decisions upstream to the mill, coater and finisher.
- Read the scope and limits of the evidence, not just the word “pass.”
- Review substitutions before they enter bulk production.
1. Turn “PFAS-free” into a usable requirement
PFAS is a large family of substances, not one chemical with one universal test. For a purchasing team, an undefined claim creates an undefined acceptance decision.
Start with the destination market, product classification, applicable date and customer restricted substances list. State which restrictions apply, whether intentional addition is prohibited, what analytical limits must be met and what evidence will support acceptance. Customer requirements may go beyond the legal minimum.
Do not treat “PFOA-free,” “PFOS-free,” “C6” or “C0” as interchangeable with a defined PFAS requirement. Commercial finish names are useful starting points for questions; they are not a complete chemical specification.
Regulatory context: two different types of requirement
EU PFHxA: Regulation (EU) 2024/2462 sets limits for PFHxA, its salts and related substances. For covered consumer clothing and related accessories, the application date is 10 October 2026; the recitals specifically mention handbags. Other covered consumer textiles have a 10 October 2027 date. The limits are 25 ppb for the sum of PFHxA and its salts and 1,000 ppb for the sum of related substances, measured in homogeneous material. Confirm the classification, exceptions and transitional provisions for each product; do not assign every bag to one date. [1]
California textile articles: DTSC identifies AB 1817 as effective from 1 January 2025. Its scope, definitions and compliance evidence must be checked separately rather than copied from an EU test request. This is a market-specific requirement, not a single US-wide PFAS rule. [2]
The broader proposed EU PFAS restriction is a separate process from restrictions already adopted. A proposal should not be presented as a blanket ban already in force. Check its current status when defining a programme. [3]
2. Follow the chemical decision beyond the sewing factory
The finished-goods factory may buy treated fabric without choosing the treatment chemistry. A declaration from that factory is therefore only the beginning of the evidence chain.
Build a risk-based material map. Review water- and stain-repellent finishes first, then relevant coatings, membranes, surface treatments and other components according to their function and supplier information. Do not assume that every coating contains PFAS—or that an untreated-looking material is automatically outside the review.
For each priority material, identify the supplier, manufacturing site, coater or finisher, material code and approved treatment. Ask who can change the formulation and whether the purchasing supplier is a producer or stockist.
A safety data sheet can support the review, but it is not a complete formulation disclosure or proof of finished-article compliance. Where proprietary chemistry limits disclosure, agree on suitable declarations, confidential verification and testing with the relevant parties.
3. Understand what a laboratory result establishes
A targeted test answers a question about specified substances using a particular method and reporting limits. “Not detected” means not detected within that scope and sensitivity; it does not prove that every PFAS is absent.
Broader fluorine measurements can provide complementary information, but they answer a different analytical question. Total fluorine, organic fluorine and a sum of individually measured PFAS are not interchangeable results. EPA discusses these coverage limitations in environmental analysis; those environmental methods should not simply be copied onto a textile testing order. Confirm matrix suitability with the laboratory. [4]
Before accepting a report, check:
- Sample identity: material code, finish, colour, supplier and sample description.
- Coverage: the named analytes, relevant sums, method, units and reporting limits.
- Acceptance basis: the requirement and version against which the result was assessed.
- Representativeness: why the submitted sample represents the material being purchased.
Agree on sample separation with the laboratory. Combining different materials can obscure a nonconforming component, particularly where a limit applies to homogeneous material. Conversely, a risk-based programme need not test every component indiscriminately.
A report does not automatically expire after a universal number of months, nor does it remain sufficient forever. Continued applicability depends on the requirement, material identity, supplier process and relevant changes.
4. Close the gap between the tested sample and bulk material
Illustrative scenario—not a reported CarryOrigin case: a development fabric passes the agreed tests. Before production, the supplier moves finishing to another site to meet the delivery date. The fabric retains its commercial code, colour and hand feel, but the process behind the original evidence has changed.
The report may still be genuine. Its applicability now needs review.
Make this review operational: purchasing must know which changes require approval, receiving must identify incoming material, and production must avoid mixing approved and unreviewed stock. The change trigger should cover the mill, finishing site, formulation, relevant process and material specification—not just the finished-bag style number.
| Gate | Minimum record | Decision owner |
|---|---|---|
| Specification | Market, product scope, restriction and customer requirement | Brand compliance / product team |
| Material approval | Material identity, treatment declaration and evidence review | Development with quality / compliance |
| Incoming material | Supplier lot linked to the approved material and purchase order | Purchasing / receiving |
| Change review | What changed, affected stock and revalidation decision | Authorised cross-functional reviewer |
| Shipment release | Applicable evidence, resolved exceptions and order traceability | Designated release authority |
These are suggested responsibilities, not statutory job titles. The arrangement must fit the company, with one accountable owner for each decision.
5. Validate the replacement against the actual product promise
Removing a fluorinated treatment is also a development decision. Define what the bag needs to do before selecting a replacement: resist light rain, prevent water penetration, resist stains, or retain performance after wear and cleaning. These are different requirements.
Surface water repellency alone does not establish that a finished bag is waterproof. Construction, seams and closures also matter. Depending on intended use, the validation plan may include spray performance, water penetration, abrasion, flexing, cleaning durability, adhesion and appearance.
Do not demand unnecessary performance simply because it appeared in an old specification. Equally, do not quietly reduce the product promise to make a replacement pass. Product development, sourcing and the brand must agree on the trade-off.
6. Treat prevention as a commercial decision
The lowest test quotation is not the same as the lowest compliance cost. Testing has limited value if the report cannot be linked to production, while poorly targeted testing can consume money without resolving the relevant risk.
Prioritise materials by treatment function, supplier transparency, change history and potential consequence. Use those factors to plan evidence collection and verification frequency. If a result is unexpected or fails the requirement, identify and hold affected material, investigate the source and agree on disposition. Repeatedly testing until a sample passes is not a corrective action.
A practical first step is to choose one active SKU and assemble a single evidence pack: the requirement, risk-based material map, supplier declarations, relevant reports, bulk-lot links and change approvals. Gaps in that pack reveal where management work is needed before scaling the process.
The question to ask before shipment
“Do we have a report?” is too narrow.
Can we show that the materials used in this order meet the applicable requirements—and that relevant changes were reviewed?
That is where PFAS control becomes part of normal purchasing, development and quality management.
Sources
- European Commission — Regulation (EU) 2024/2462, PFHxA restriction.
- California DTSC — PFAS in Consumer Products factsheet. See also the AB 1817 legislative record for the enacted provisions.
- ECHA — PFAS, existing restrictions and the broader restriction process.
- US EPA — Environmental Forensic Tools for Understanding PFAS Fate and Transport. Analytical scope context only; not a textile test specification.
Related: Turning an approved sample into a production standard · The Compliance Shield
Discuss a material-control or supplier-evidence gap with CarryOrigin →